Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	64	73	57	28	40	30	Upgrade
Market Cap Growth	26.92%	26.92%	106.35%	-30.15%	32.84%	38.29%	Upgrade
Enterprise Value	66	75	57	34	39	29	Upgrade
Last Close Price	14.63	16.50	13.00	6.30	9.02	6.79	Upgrade
PS Ratio	53.71	60.58	-	2.49	15.90	-	Upgrade
PB Ratio	3.69	4.17	2.86	1.13	1.23	0.75	Upgrade
P/TBV Ratio	3.69	4.17	3.01	1.17	1.27	0.77	Upgrade
P/FCF Ratio	-	-	-	15.96	-	-	Upgrade
P/OCF Ratio	-	-	-	15.96	-	-	Upgrade
EV/Sales Ratio	54.60	62.60	-	3.05	15.60	-	Upgrade
EV/FCF Ratio	-	-	-	19.52	-	-	Upgrade
Debt / Equity Ratio	0.09	0.09	0.03	-	0.04	0.03	Upgrade
Asset Turnover	0.06	0.06	-	0.36	0.05	-	Upgrade
Inventory Turnover	-	-	-	-	1.20	0.46	Upgrade
Quick Ratio	5.26	5.26	10.83	0.60	0.33	0.44	Upgrade
Current Ratio	6.07	6.07	12.17	1.89	1.87	4.28	Upgrade
Return on Equity (ROE)	-13.46%	-13.46%	-20.71%	-26.64%	-20.88%	-38.19%	Upgrade
Return on Assets (ROA)	-7.73%	-7.73%	-11.06%	-16.64%	-9.64%	-9.87%	Upgrade
Return on Capital (ROIC)	-8.40%	-8.40%	-12.14%	-17.92%	-12.88%	-16.09%	Upgrade
Earnings Yield	-3.91%	-3.47%	-8.07%	-27.30%	-18.90%	-62.70%	Upgrade
FCF Yield	-	-0.74%	-6.00%	6.26%	-1.23%	-77.72%	Upgrade
Buyback Yield / Dilution	-0.39%	-0.39%	-	-	-	-2.66%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.